WHO ICTRP trial
A randomized, double-blind, controlled study of KIB-PCI in Japanese healthy…
JPRN-jRCT2080221923 · Japan Primary Registries Network (JPRN)
Key facts
| Trial ID | JPRN-jRCT2080221923 |
|---|---|
| Public title | A randomized, double-blind, controlled study of KIB-PCI in Japanese healthy adult volunteers |
| Scientific title | A randomized, double-blind, controlled study of KIB-PCI in Japanese healthy adult volunteers |
| Primary sponsor | DAIICHISANKYO Co.,Ltd. |
| Secondary sponsors | KITASATO DAIICHI SANKYO VACCINE COMPANY, LIMITED |
| Registry | Japan Primary Registries Network (JPRN) |
| Study type | Interventional |
| Phase | 3 |
| Conditions | Prophylaxis of new type of influenza virus infection |
| Interventions | investigational material(s) Generic name etc : KIB-PCI INN of investigational material : Therapeutic category code : 631 Vaccines Dosage and Administration for Investigational material : intramuscular control material(s) Generic name etc… |
| Registration date | Sep 20, 2012 |
| Target size | 800 |
| Secondary IDs | JapicCTI-121968 |
| Registry page | jrct.niph.go.jp |
At a glance
- No Results available
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About WHO ICTRP trial registrations
The WHO ICTRP combines trial registrations from primary registries worldwide into a single searchable index. Contact and ethics-committee details are not shown here.
Source: World Health Organization (WHO), International Clinical Trials Registry Platform (ICTRP) · Source date: